Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Nature Communications|July 1, 2018
Targeting EZH2 reactivates a breast cancer subtype-specific anti-metastatic transcriptional programAlison Hirukawa, Harvey W Smith, Dongmei Zuo, et al.
Nature Communications|June 15, 2026
HER2∆16 directs luminal cell identity and estrogen receptor signaling in HER2+ breast cancerHailey Proud, Elizabeth Podleszanski, Sherif S Attalla, et al.
Nature Communications|July 13, 2016
ERRα mediates metabolic adaptations driving lapatinib resistance in breast cancerGeneviève Deblois, Harvey W Smith, Ingrid S Tam, et al.
Cell Reports|October 10, 2019
Reduction of Global H3K27me3 Enhances HER2/ErbB2 Targeted TherapyAlison Hirukawa, Salendra Singh, Jarey Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 31, 2020
An ErbB2 splice variant lacking exon 16 drives lung carcinomaHarvey W Smith, Lei Yang, Chen Ling, et al.
EMBO Reports|January 28, 2026
EZH2 directs HER2+ breast cancer progression through the modulation of epithelial plasticityLinshan Liu, Ellie J Massey, Dongmei Zuo, et al.
Communications Biology|September 12, 2022
Integrated multi-omics analysis of adverse cardiac remodeling and metabolic inflexibility upon ErbB2 and ERRα deficiencyCatherine R Dufour, Hui Xia, Wafa B'chir, et al.
The Journal of Clinical Investigation|February 16, 2023
Coordinated activation of c-Src and FOXM1 drives tumor cell proliferation and breast cancer progressionIpshita Nandi, Harvey W Smith, Virginie Sanguin-Gendreau, et al.
Cell Reports|March 22, 2018
KIBRA (WWC1) Is a Metastasis Suppressor Gene Affected by Chromosome 5q Loss in Triple-Negative Breast CancerJennifer F Knight, Vanessa Y C Sung, Elena Kuzmin, et al.
Nature Communications|July 3, 2019
An ErbB2/c-Src axis links bioenergetics with PRC2 translation to drive epigenetic reprogramming and mammary tumorigenesisHarvey W Smith, Alison Hirukawa, Virginie Sanguin-Gendreau, et al.
Pageof 2